Pure Global AI
European Union flag

European Union medical device registration timeline

Source-linked clocks

Notified Bodies under EU MDR 2017/745 (EU MDR) review clocks and end-to-end planning ranges, using the 4-class (I, IIa, IIb, III) classification system.

1 pathways1 of 1 clocks verifiedvalidity 5 years (CE certificate)MDSAP not acceptedreviewed 2026-08-29eur-lex.europa.eu
Class / pathwayReview clockPlanning totalWith prior approvalProvenance
Class I(Self-declaration (no notified body))

MDR Art. 52(7): non-sterile, non-measuring, non-reusable-surgical Class I devices are self-declared, so no authority or notified body reviews the file and there is no review clock

Elapsed time is Eudamed actor and device registration, which has no guaranteed processing time, plus any national registration duty

0 days6-9 months—Verified
Review clocks exclude applicant hold time · planning totals are estimates

Planning steps and estimates; these are not regulator deadlines.

European Union Medical Device Registration Process

Step-by-step EU MDR registration process. Total estimated timeline: 6-9 months.

Step 1: Device Classification

2-4 weeks

Classify device under EU MDR Annex VIII rules. Determine conformity assessment route.

Step 2: Appoint EC REP

2-4 weeks

Foreign manufacturers must appoint an EU Authorized Representative (EC REP) for regulatory correspondence.

Step 3: Technical Documentation

3-9 months

Prepare EU MDR-compliant technical file including clinical evaluation, risk management, and biocompatibility.

Step 4: Notified Body Engagement

6-18 months

Contract with Notified Body (BSI, TUV, etc). NB capacity is limited; queue times 6-18 months.

Step 5: Conformity Assessment

6-12 months

Notified Body audits QMS (ISO 13485) and reviews technical documentation. May conduct facility audit.

Step 6: CE Marking

1-2 weeks

Upon successful assessment, affix CE mark. Register in EUDAMED. Certificate valid 5 years.

Summary: The European Union medical device registration process through Notified Bodies under EU MDR 2017/745 (EU MDR) consists of 6 main steps: Device Classification → Appoint EC REP → Technical Documentation → Notified Body Engagement → Conformity Assessment → CE Marking.
Expedited pathways
Article 59 DerogationImmediate market access

National-level exemption for public health emergencies

Eligibility: Public health emergencies only, Not for commercial reasons

Legacy Device TransitionUntil Dec 2027 (Class III) or Dec 2028 (others)

Extended deadlines for MDD-certified devices

Eligibility: Valid MDD certificate on Mar 20, 2023, No significant changes

Prior approval recognition
FDA 510(k)Clinical data can be leveraged2-4 months prep time
MDD CE MarkExtended market access during transitionUntil 2027-2028
ISO 13485QMS foundation for MDR2-4 months
Key requirements
  • EU Authorized Representative (for non-EU manufacturers)
  • Technical Documentation (Annex II & III)
  • Clinical Evaluation Report
  • Post-Market Surveillance system
  • EUDAMED registration
  • UDI implementation
  • Clinical investigation clocks (MDR Art. 70): member state notifies validation within 10 days; sponsor completes application within max 10 days (+20 extension); authorisation decision within 45 days of validation (+20 with expert extension); clock suspended during information requests (IVDR Art. 66/74 analogous)
  • Notified-body certification became time-bound only with Implementing Regulation (EU) 2026/977: before it applies on 25 Feb 2027 the review duration is purely contractual, and Art. 8(1) leaves procedures contracted before that date uncapped
  • Re-certification under Reg. (EU) 2026/977 Arts. 5-7: the notified body assesses the renewal documentation within 90 days and issues the certificate within a further 20 days, and Art. 8(3) excludes certificates expiring before 25 Nov 2027
  • Substantial changes to an approved quality system or device under Reg. (EU) 2026/977 Art. 2(3): 30 days to review the planned change, 90 days for any additional assessment, 20 days to issue the certificate supplement
  • Notified bodies must quote estimated cost and timeline up front and flag any cost increase above 10% (Reg. (EU) 2026/977 Art. 1), and from 1 Jan 2028 publish annual median duration and cost figures (Art. 4(4))
  • NB surveillance audits at least every 12 months and unannounced audits at least every 5 years
Primary regulator sources

Reviewed 2026-08-29. End-to-end totals remain planning estimates.

Keep researching this market
View the European Union resource hub →
Compare timeline across all countries →
Source-linked review clocks verified against EU MDR publications · full review 2026-08-29 · row IDs are stable — cite as registration-timeline:eu:class-i